Characteristics | Media (range) or N (%) |
---|---|
Media of age (years) | 46 (23–68) |
Media of follow-up (months) | 67 (6 –90) |
Pathologic type | |
Squamous | 506 (83.1) |
Adenocarcinoma | 74 (12.2) |
Adenosquamous | 29 (4.7) |
Size of primary tumor | |
≤4 cm | 481 (79.0) |
>4 cm | 128 (21.0) |
Histologic grade | |
G1 | 61 (10.0) |
G2 | 243 (39.9) |
G3 | 305 (50.1) |
Depth of primary tumor invasion | |
≤1/2 | 355 (58.3) |
>1/2 | 254 (41.7) |
Stage (FIGO) | |
IA2 | 95 (15.6) |
IB1 | 317 (52.1) |
IB2 | 73 (12.0) |
IIA1 | 69 (11.3) |
IIA2 | 55 (9.0) |
Lymph-vascular space invasion | |
No | 518 (85.1) |
Yes | 91 (14.9) |
Lymphadenectomy | |
Pelvic | 549 (90.1) |
Pelvic + Periaortic | 60 (9.9) |
Neo-adjuvant chemotherapy | |
Yes | 128 (21.0) |
No | 481 (79.0) |
Adjuvant therapy | |
None | 451 (74.1) |
Concurrent chemoradiation | 158 (25.9) |
Lymph nodes metastasis | |
No | 516 (84.7) |
Yes | 93 (15.3) |